Placental ABC transporters, cellular toxicity and stress in pregnancy

• Published in: Chemico-biological interactions 2013-04, Vol.203 (2), p.456-466
• Main Authors: Aye, Irving L.M.H., Keelan, Jeffrey A.
• Format: Article
• Language: English
• Subjects: ABC transporters; Active transport; animal models; Animals; ATP-Binding Cassette Transporters - metabolism; cells; clinical trials; Cytotoxicity; Cytotoxins - metabolism; Cytotoxins - toxicity; Female; fetal development; fetus; gestational diabetes; glutathione; Humans; hypoxia; Inflammation; metabolites; Oxidative Stress; Placenta; Placenta - cytology; Placenta - metabolism; pre-eclampsia; Pregnancy; sterols; toxins; Trophoblast; viability; xenobiotics; Xenobiotics - metabolism
• ISSN: 0009-2797; 1872-7786
• DOI: 10.1016/j.cbi.2013.03.007

The human placenta, in addition to its roles as a nutrient transfer and endocrine organ, functions as a selective barrier to protect the fetus against the harmful effects of exogenous and endogenous toxins. Members of the ATP-binding cassette (ABC) family of transport proteins limit the entry of xenobiotics into the fetal circulation via vectorial efflux from the placenta to the maternal circulation. Several members of the ABC family, including proteins from the ABCA, ABCB, ABCC and ABCG subfamilies, have been shown to be functional in the placenta with clinically significant roles in xenobiotic efflux. However, recent findings suggest that these transporters also protect placental tissue by preventing the cellular accumulation of cytotoxic compounds such as lipids, sterols and their derivatives. Such protective functions are likely to be particularly important in pregnancies complicated by inflammatory or oxidative stress, where the generation of toxic metabolites is enhanced. For example, ABC transporters have been shown to protect against the harmful effects of hypoxia and oxidative stress through increased expression and efflux of oxysterols and glutathione conjugated xenobiotics. However, this protective capacity may be diminished in response to the same stressors. Several studies in primary human trophoblast cells and animal models have demonstrated decreased expression and activity of placental ABC transporters with inflammatory, oxidative or metabolic stress. Several clinical studies in pregnancies complicated by inflammatory conditions such as preeclampsia and gestational diabetes support these findings, although further studies are required to determine the clinical relevance of the relationships between placental ABC transporter expression and activity, and placental function in stressed pregnancies. Such studies are necessary to fully understand the consequences of pregnancy disorders on placental function and viability in order to optimise pregnancy care and maximise fetal growth and health.